You qualify if you purchased Branded or authorized generic EpiPens between August 24, 2011, and November 1, 2020 in Alabama, California, Florida, Hawaii, Illinois, Kansas, Maine, Michigan, Minnesota, Mississippi, Nebraska, Nevada, New Hampshire, New York, North Carolina, Tennessee, or Utah. No proof of purchase is necessary.
